FSA
CALA

Franklin Street Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Franklin Street Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,685
Closed -$54K – 160
2022
Q1 		$54K Hold
6,685
– – ﹤0.01% 156
2021
Q4 		$89K Hold
6,685
– – 0.01% 164
2021
Q3 		$291K Buy
6,685
+6
+0.1% +$259 0.02% 129
2021
Q2 		$279K Sell
6,679
-250
-4% -$11K 0.02% 128
2021
Q1 		$335K Buy
6,929
+1,300
+23% +$75.7K 0.03% 120
2020
Q4 		$553K Hold
5,629
– – 0.05% 101
2020
Q3 		$388K Hold
5,629
– – 0.04% 107
2020
Q2 		$594K Hold
5,629
– – 0.07% 91
2020
Q1 		$500K Hold
5,629
– – 0.07% 92
2019
Q4 		$643K Hold
5,629
– – 0.08% 94
2019
Q3 		$348K Hold
5,629
– – 0.04% 116
2019
Q2 		$439K Buy
5,629
+1,500
+36% +$170K 0.06% 110
2019
Q1 		$557K Hold
4,129
– – 0.08% 99
2018
Q4 		$331K Buy
4,129
+50
+1% +$4.93K 0.05% 111
2018
Q3 		$428K Hold
4,079
– – 0.06% 109
2018
Q2 		$408K Sell
4,079
-250
-6% -$28.3K 0.06% 111
2018
Q1 		$545K Buy
4,329
+1,550
+56% +$242K 0.08% 93
2017
Q4 		$464K Buy
2,779
+1,000
+56% +$256K 0.07% 111
2017
Q3 		$560K Buy
1,779
+50
+3% +$15.8K 0.09% 96
2017
Q2 		$514K Sell
1,729
-2,000
-54% -$535K 0.09% 97
2017
Q1 		$861K Sell
3,729
-2,500
-40% -$432K 0.15% 88
2016
Q4 		$405K Buy
6,229
+1,229
+25% +$76.8K 0.07% 130
2016
Q3 		$325K Buy
5,000
+785
+19% +$50.6K 0.06% 145
2016
Q2 		$313K Sell
4,215
-230
-5% -$23K 0.06% 154
2016
Q1 		$505K Buy
4,445
+1,782
+67% +$202K 0.1% 137
2015
Q4 		$408K Sell
2,663
-685
-20% -$103K 0.08% 156
2015
Q3 		$364K Buy
3,348
+1,985
+146% +$257K 0.07% 162
2015
Q2 		$195K Buy
+1,363
New +$316K 0.03% 210
2015
Q1 		– Sell
-533
Closed -$215K – 221
2014
Q4 		$215K Buy
+533
New +$139K 0.04% 181

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Street Advisors's CALA Position: Q2 2022 in Review

Franklin Street Advisors sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 6,685 shares — an estimated $54K sold.

Franklin Street Advisors first reported a position in CALA in Q4 2014 and held it in 29 quarters. The position peaked at $861K in Q1 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Franklin Street Advisors reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Franklin Street Advisors sold 6,685 Calithera Biosciences, Inc shares in Q2 2022, an estimated $54K.
  • Franklin Street Advisors first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 29 quarters.
  • Franklin Street Advisors's Calithera Biosciences, Inc position peaked at $861K in Q1 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Franklin Street Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.